Mark Lanasa
Corporate Officer/Principal chez BEIGENE, LTD.
Profil
Mark Lanasa is currently the Chief Medical Officer & SVP-Solid Tumors at BeiGene Ltd.
Prior to this, he worked as the Vice President & Head-Enhertu Global Clinical at AstraZeneca PLC.
He completed his undergraduate degree at The Pennsylvania State University and holds graduate and doctorate degrees from the University of Pittsburgh School of Medicine.
Postes actifs de Mark Lanasa
| Sociétés | Poste | Début |
|---|---|---|
| BEIGENE, LTD. | Corporate Officer/Principal | 09/02/2022 |
Anciens postes connus de Mark Lanasa
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Formation de Mark Lanasa
| The Pennsylvania State University | Undergraduate Degree |
| University of Pittsburgh School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| BEIGENE, LTD. | Health Technology |
